2025-02-27
#reports #ZVIA
[Zevia PBC](https://eninvs.com/all.php?name=ZVIA) (Beverages — Non-Alcoholic) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=180971)
(2025-02-26, Before Market Open):
- Revenue +2.6% YoY (vs -16.3% in previous quarter and historical rate -1.6%)
- EBITDA margin -15.4% increased compared to -23.7% same period last year
- Net Debt increased by $4 mln over the past reporting period (2.9% of market cap)
- FCF (LTM) -$0 bln (negative), 2.2% of market cap
- EV/Sales multiple is 0.6x
At the opening of the session the share price went down -14.1% vs S&P500 +0.2%
------------------------------------------------
2025-02-27
#reports #ZETA
[Zeta Global Holdings Corp.](https://eninvs.com/all.php?name=ZETA) (Software — Application) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=180970)
(2025-02-25, After Market Close):
- Revenue +50% YoY (vs +41.8% in previous quarter and historical rate +30.3%)
- EBITDA margin 7.6% increased compared to -8.6% same period last year
- Net Debt increased by $52 mln over the past reporting period (1.6% of market cap)
- FCF (LTM) +$0.3 bln (positive), 8.2% of market cap
- EV/Sales multiple is 3.2x
At the opening of the session the share price went down -0.6% vs S&P500 +0.2%
------------------------------------------------
2025-02-27
#reports #XPER
[Xperi](https://eninvs.com/all.php?name=XPER) (Semiconductor Equipment and Materials) reported for 2024 q4
(2025-02-26, After Market Close):
- Revenue -10.9% YoY (vs +2.3% in previous quarter and historical rate -14.4%)
- EBITDA margin -9.0% increased compared to -19.0% same period last year
- Net Debt decreased by $54 mln over the past reporting period (15.0% of market cap)
- FCF (LTM) -$0.1 bln (negative), 29.2% of market cap
- EV/Sales multiple is 0.7x
------------------------------------------------
2025-02-27
#reports #XPEL
[XPEL](https://eninvs.com/all.php?name=XPEL) (Automotive surface protection products manufacturer) reported for 2024 q4
(2025-02-26, Before Market Open):
- Revenue +1.9% YoY (vs +9.7% in previous quarter and historical rate +18.1%)
- EBITDA -12.5% YoY (vs +5.3% in previous quarter and historical rate +15.7%)
- EBITDA margin 13.0% decreased compared to 15.1% same period last year
- Net Debt decreased by $14 mln over the past reporting period (1.5% of market cap)
- FCF (LTM) +$0 bln (positive), 1.6% of market cap
- EV/EBITDA multiple is 14.6x compared to historical level (75th percentile) of 33.4x
- EV/Sales multiple is 2.3x
At the opening of the session the share price went down -16.4% vs S&P500 +0.2%
------------------------------------------------
2025-02-27
#reports #XMTR
[Xometry, Inc.](https://eninvs.com/all.php?name=XMTR) (Specialty Industrial Machinery) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=181104)
(2025-02-25, Before Market Open):
- Revenue +16.4% YoY (vs +19.3% in previous quarter and historical rate +34.1%)
- EBITDA margin -5.4% increased compared to -7.8% same period last year
- Net Debt decreased by $8 mln over the past reporting period (0.6% of market cap)
- FCF (LTM) -$0 bln (negative), 2.4% of market cap
- EV/Sales multiple is 2.5x
At the opening of the session the share price went down -5.0% vs S&P500 -0.4%
------------------------------------------------
2025-02-27
#reports #XHR
[Xenia Hotels & Resorts](https://eninvs.com/all.php?name=XHR) (REIT — Hotel and Motel) reported for 2024 q4
(2025-02-25, Before Market Open):
- Revenue +3.6% YoY (vs +2.2% in previous quarter and historical rate +26.3%)
- EBITDA +3.8% YoY (vs -4.9% in previous quarter and historical rate +44.5%)
- EBITDA margin 21.0% has not changed compared to 20.9% same period last year
- Net Debt decreased by $1.3 bln since the start of the year (84.4% of market cap)
- EV/EBITDA multiple is 12.8x compared to historical level (75th percentile) of 13.9x
- EV/Sales multiple is 2.7x
At the opening of the session the share price went down -2.9% vs S&P500 -0.4%
------------------------------------------------
2025-02-27
#reports #WK
[Workiva](https://eninvs.com/all.php?name=WK) (Software — Application) reported for 2024 q4
(2025-02-25, After Market Close):
- Revenue +19.8% YoY (vs +17.7% in previous quarter and historical rate +18.6%)
- EBITDA margin -5.0% decreased compared to -4.2% same period last year
- Net Debt decreased by $38 mln over the past reporting period (0.8% of market cap)
- FCF (LTM) -$0 bln (negative), 0.1% of market cap
- EV/Sales multiple is 6.7x
At the opening of the session the share price went up +3.0% vs S&P500 +0.2%
------------------------------------------------
2025-02-27
#reports #VRSK
[Verisk Analytics](https://eninvs.com/all.php?name=VRSK) (Analytical service provider) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=180929)
(2025-02-26, Before Market Open):
- Revenue +8.7% YoY (vs +6.9% in previous quarter and historical rate -0.8%)
- EBITDA -52.4% YoY (vs +7.5% in previous quarter and historical rate +11.5%)
- EBITDA margin 42.9% decreased compared to 98.1% same period last year
- Net Debt increased by $154 mln over the past reporting period (0.4% of market cap)
- FCF (LTM) +$0.2 bln (positive), 0.4% of market cap
- EV/EBITDA multiple is 27x compared to historical level (75th percentile) of 22.6x
- EV/Sales multiple is 15.2x
At the opening of the session the share price went down -11.8% vs S&P500 +0.2%
------------------------------------------------
2025-02-27
#reports #VAC
[Marriott Vacations Worldwide Corporation](https://eninvs.com/all.php?name=VAC) (Vacation services provider) reported for 2024 q4
(2025-02-26, After Market Close):
- Revenue +11.1% YoY (vs +10.0% in previous quarter and historical rate +9.4%)
- EBITDA +4.8% YoY (vs +12.3% in previous quarter and historical rate +79.4%)
- EBITDA margin 59.8% decreased compared to 63.4% same period last year
- Net Debt decreased by $454 mln over the past reporting period (12.5% of market cap)
- EV/EBITDA multiple is 1.4x compared to historical level (75th percentile) of 11.2x
- EV/Sales multiple is 0.8x
------------------------------------------------
2025-02-27
#reports #UTHR
[United Therapeutics](https://eninvs.com/all.php?name=UTHR) (Medicines manufacturer) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=180906)
(2025-02-26, Before Market Open):
- Revenue +19.7% YoY (vs +23.0% in previous quarter and historical rate +19.8%)
- EBITDA +36% YoY (vs +6.5% in previous quarter and historical rate +32.7%)
- EBITDA margin 50.3% increased compared to 44.2% same period last year
- Net Debt increased by $1.2 bln since the start of the year (8.0% of market cap)
- FCF (LTM) +$1.6 bln (positive), 11.3% of market cap
- EV/EBITDA multiple is 9.3x compared to historical level (75th percentile) of 10.7x
- EV/Sales multiple is 4.6x
------------------------------------------------
2025-02-27
#reports #UHS
[Universal Health Services](https://eninvs.com/all.php?name=UHS) (Medical services provider) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=180982)
(2025-02-26, After Market Close):
- Revenue +424.6% YoY (vs +156.8% in previous quarter and historical rate +15.9%)
- EBITDA +73.2% YoY (vs +32.8% in previous quarter and historical rate +8.5%)
- EBITDA margin 9.0% decreased compared to 27.2% same period last year
- Net Debt decreased by $156 mln over the past reporting period (1.2% of market cap)
- FCF (LTM) +$0.2 bln (positive), 1.7% of market cap
- EV/EBITDA multiple is 8x compared to historical level (75th percentile) of 10.5x
- EV/Sales multiple is 1.1x
At the opening of the session the share price went up +0.3% vs S&P500 +0.3%
------------------------------------------------
2025-02-27
#reports #UFPT
[UFP Technologies](https://eninvs.com/all.php?name=UFPT) (Medical Devices) reported for 2024 q4
(2025-02-25, Before Market Open):
- Revenue +42.6% YoY (vs +43.6% in previous quarter and historical rate +37.1%)
- EBITDA +66.7% YoY (vs +57.9% in previous quarter and historical rate +52.5%)
- EBITDA margin 17.4% increased compared to 14.9% same period last year
- Net Debt decreased by $36 mln over the past reporting period (2.0% of market cap)
- FCF (LTM) -$0.2 bln (negative), 10.4% of market cap
- EV/EBITDA multiple is 20.9x compared to historical level (75th percentile) of 26.8x
- EV/Sales multiple is 3.9x
At the opening of the session the share price went up +5.8% vs S&P500 -0.4%
------------------------------------------------
2025-02-27
#reports #TZOO
[Travelzoo](https://eninvs.com/all.php?name=TZOO) (Advertising Agencies) reported for 2024 q4
(2025-02-25, Before Market Open):
- Revenue 0% YoY (vs -4.8% in previous quarter and historical rate +11.2%)
- EBITDA 0% YoY (vs 0.0% in previous quarter and historical rate +49.0%)
- EBITDA margin 23.8% has not changed compared to 23.8% same period last year
- Net Debt decreased by $4 mln over the past reporting period (2.1% of market cap)
- FCF (LTM) +$0 bln (positive), 4.1% of market cap
- EV/EBITDA multiple is 9.9x compared to historical level (75th percentile) of 9.3x
- EV/Sales multiple is 2.2x
At the opening of the session the share price went down -19.0% vs S&P500 -0.4%
------------------------------------------------
2025-02-27
#reports #TNDM
[Tandem Diabetes Care](https://eninvs.com/all.php?name=TNDM) (Medical equipment manufacturer) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=180928)
(2025-02-26, After Market Close):
- Revenue +43.7% YoY (vs +31.2% in previous quarter and historical rate +11.3%)
- EBITDA margin 1.4% increased compared to -15.2% same period last year
- Net Debt increased by $32 mln over the past reporting period (1.5% of market cap)
- FCF (LTM) -$0.1 bln (negative), 2.6% of market cap
- EV/Sales multiple is 2.3x
At the opening of the session the share price went down -0.1% vs S&P500 +0.3%
------------------------------------------------
2025-02-27
#reports #TIPT
[Tiptree](https://eninvs.com/all.php?name=TIPT) (Insurance — Specialty) reported for 2024 q4
(2024-10-30, Before Market Open):
- Revenue +16.4% YoY (vs +18.5% in previous quarter and historical rate +19.5%)
- Net Income -25.6% YoY (vs +122.2% in previous quarter and historical rate +43.3%)
- Net Income margin 5.8% decreased compared to 9.0% same period last year
- P/E multiple is 9.3x compared to historical level (75th percentile) of 22.3x
- P/S multiple is 0.4x
- Price to book: 1.7x
At the opening of the session the share price went down -0.4% vs S&P500 0.0%
------------------------------------------------
2025-02-27
#reports #TDOC
[Teladoc Health](https://eninvs.com/all.php?name=TDOC) (Health care provider) reported for 2024 q4
(2025-02-26, After Market Close):
- Revenue -3.2% YoY (vs -2.9% in previous quarter and historical rate +8.5%)
- EBITDA -168.3% YoY (vs -240.0% in previous quarter and historical rate -14.0%)
- EBITDA margin -6.7% decreased compared to 9.5% same period last year
- Net Debt decreased by $58 mln over the past reporting period (5.8% of market cap)
- FCF (LTM) +$0.1 bln (positive), 12.5% of market cap
- EV/Sales multiple is 0.5x
------------------------------------------------
2025-02-27
#reports #TBPH
[Theravance Biopharma](https://eninvs.com/all.php?name=TBPH) (Biotechnology) reported for 2024 q4
(2025-02-26, After Market Close):
- Revenue +5.6% YoY (vs -70.7% in previous quarter and historical rate +23.7%)
- EBITDA -9.4% YoY (vs -143.5% in previous quarter and historical rate +27.3%)
- EBITDA margin 152.6% decreased compared to 177.8% same period last year
- Net Debt decreased by $3 mln over the past reporting period (0.4% of market cap)
- FCF (LTM) -$0 bln (negative), 1.6% of market cap
- EV/Sales multiple is 9.5x
------------------------------------------------
2025-02-27
#reports #SUPN
[Supernus Pharmaceuticals](https://eninvs.com/all.php?name=SUPN) (Pharmaceutical manufacturer) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=181070)
(2025-02-25, After Market Close):
- Revenue +93.9% YoY (vs +14.3% in previous quarter and historical rate +12.8%)
- EBITDA +152.4% YoY (vs +100.0% in previous quarter and historical rate +37.8%)
- EBITDA margin 16.7% increased compared to 12.8% same period last year
- Net Debt decreased by $52 mln over the past reporting period (3.0% of market cap)
- FCF (LTM) +$0.2 bln (positive), 8.6% of market cap
- EV/EBITDA multiple is 7.5x compared to historical level (75th percentile) of 19.3x
- EV/Sales multiple is 1.7x
At the opening of the session the share price went up +2.7% vs S&P500 +0.2%
------------------------------------------------
2025-02-27
#reports #SSTK
[Shutterstock](https://eninvs.com/all.php?name=SSTK) (Photo and video sharing platform) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=181089)
(2025-02-25, Before Market Open):
- Revenue +15.2% YoY (vs +7.7% in previous quarter and historical rate +6.6%)
- EBITDA +63.6% YoY (vs +5.3% in previous quarter and historical rate +5.2%)
- EBITDA margin 14.4% increased compared to 10.1% same period last year
- Net Debt increased by $190 mln over the past reporting period (23.7% of market cap)
- FCF (LTM) -$0 bln (negative), 3.5% of market cap
- EV/EBITDA multiple is 6.4x compared to historical level (75th percentile) of 12x
- EV/Sales multiple is 1.1x
At the opening of the session the share price went up +0.3% vs S&P500 -0.4%
------------------------------------------------
2025-02-27
#reports #SSTI
[ShotSpotter](https://eninvs.com/all.php?name=SSTI) (Software — Application) reported for 2024 q4
(2025-02-25, After Market Close):
- Revenue -11.5% YoY (vs +8.3% in previous quarter and historical rate +25.6%)
- EBITDA -80% YoY (vs -100.0% in previous quarter)
- EBITDA margin 8.7% decreased compared to 38.5% same period last year
- Net Debt increased by $2 mln over the past reporting period (1.0% of market cap)
- FCF (LTM) +$0 bln (positive), 5.8% of market cap
- EV/Sales multiple is 1.9x
At the opening of the session the share price went down -3.1% vs S&P500 +0.2%
------------------------------------------------
2025-02-27
#reports #SRI
[Stoneridge](https://eninvs.com/all.php?name=SRI) (Automotive electronic equipment manufacturer) reported for 2024 q4
(2025-02-26, After Market Close):
- Revenue +201.7% YoY (vs -10.1% in previous quarter and historical rate +23.3%)
- EBITDA 0% YoY (vs -38.5% in previous quarter and historical rate +15.0%)
- EBITDA margin 1.9% decreased compared to 5.7% same period last year
- Net Debt decreased by $13 mln over the past reporting period (11.2% of market cap)
- FCF (LTM) +$0 bln (positive), 5.2% of market cap
- EV/EBITDA multiple is 8.4x compared to historical level (75th percentile) of 17x
- EV/Sales multiple is 0.2x
------------------------------------------------
2025-02-27
#reports #SPTN
[SpartanNash](https://eninvs.com/all.php?name=SPTN) (Food Distribution) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=181008)
(2025-02-12, Before Market Open):
- Revenue +0.8% YoY (vs -0.6% in previous quarter and historical rate +2.4%)
- EBITDA -104% YoY (vs +24.4% in previous quarter and historical rate +5.8%)
- EBITDA margin -0.1% decreased compared to 2.2% same period last year
- Net Debt increased by $221 mln over the past reporting period (33.0% of market cap)
- FCF (LTM) +$0 bln (positive), 1.3% of market cap
- EV/EBITDA multiple is 6.1x compared to historical level (75th percentile) of 7.7x
- EV/Sales multiple is 0.1x
At the opening of the session the share price went up +2.1% vs S&P500 -0.7%
------------------------------------------------
2025-02-27
#reports #SNPS
[Synopsys](https://eninvs.com/all.php?name=SNPS) (Electronics design technology provider) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=181010)
(2025-02-26, After Market Close):
- Revenue -11.8% YoY (vs -6.3% in previous quarter and historical rate +10.4%)
- EBITDA -22.9% YoY (vs -89.0% in previous quarter and historical rate +12.8%)
- EBITDA margin 23.4% decreased compared to 26.7% same period last year
- Net Debt increased by $3.3 bln since the start of the year (4.6% of market cap)
- FCF (LTM) +$0.4 bln (positive), 0.6% of market cap
- EV/EBITDA multiple is 44.3x compared to historical level (75th percentile) of 50.2x
- EV/Sales multiple is 11.6x
------------------------------------------------
2025-02-27
#reports #SMCI
[Super Micro Computer](https://eninvs.com/all.php?name=SMCI) (Computer Hardware) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=181075)
(2025-02-11, After Market Close):
- Revenue +54.9% YoY (vs +180.0% in previous quarter and historical rate +80.1%)
- EBITDA -1.1% YoY (vs +181.9% in previous quarter and historical rate +110.1%)
- EBITDA margin 6.6% decreased compared to 10.3% same period last year
- EV/EBITDA multiple is 2.2x compared to historical level (75th percentile) of 22.6x
- EV/Sales multiple is 0.2x
At the opening of the session the share price went up +8.2% vs S&P500 -0.7%
------------------------------------------------
2025-02-27
#reports #SLNG
[Stabilis Solutions](https://eninvs.com/all.php?name=SLNG) (Oil and Gas Integrated) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=181031)
(2025-02-25, After Market Close):
- Revenue -5.6% YoY (vs +20.0% in previous quarter and historical rate +11.7%)
- EBITDA 0% YoY (vs 0.0% in previous quarter and historical rate +18.1%)
- EBITDA margin 17.6% increased compared to 16.7% same period last year
- Net Debt increased by $3 mln over the past reporting period (2.5% of market cap)
- FCF (LTM) +$0 bln (positive), 5.8% of market cap
- EV/EBITDA multiple is 11.8x compared to historical level (75th percentile) of 16x
- EV/Sales multiple is 1.6x
At the opening of the session the share price went down -4.0% vs S&P500 +0.2%
------------------------------------------------
2025-02-27
#reports #SHOO
[Steven Madden](https://eninvs.com/all.php?name=SHOO) (Women`s shoes manufacturer) reported for 2024 q4
(2025-02-26, Before Market Open):
- Revenue +11.9% YoY (vs +13.0% in previous quarter and historical rate +9.5%)
- EBITDA +18.2% YoY (vs -8.0% in previous quarter and historical rate +4.8%)
- EBITDA margin 8.9% increased compared to 8.5% same period last year
- Net Debt decreased by $60 mln over the past reporting period (2.4% of market cap)
- FCF (LTM) -$0.1 bln (negative), 2.6% of market cap
- EV/EBITDA multiple is 10x compared to historical level (75th percentile) of 13x
- EV/Sales multiple is 1.1x
At the opening of the session the share price went down -0.2% vs S&P500 +0.2%
------------------------------------------------
2025-02-27
#reports #SHLS
[Shoals Technologies Group, Inc.](https://eninvs.com/all.php?name=SHLS) (Solar) reported for 2024 q4
(2025-02-25, Before Market Open):
- Revenue -17.7% YoY (vs -23.9% in previous quarter and historical rate +29.1%)
- EBITDA -42.9% YoY (vs +700.0% in previous quarter and historical rate +75.8%)
- EBITDA margin 18.7% decreased compared to 26.9% same period last year
- Net Debt decreased by $154 mln over the past reporting period (23.8% of market cap)
- FCF (LTM) -$0.1 bln (negative), 17.4% of market cap
- EV/EBITDA multiple is 11.6x compared to historical level (75th percentile) of 49.7x
- EV/Sales multiple is 1.9x
At the opening of the session the share price went down -15.0% vs S&P500 -0.4%
------------------------------------------------
2025-02-27
#reports #SG
[Sweetgreen, Inc.](https://eninvs.com/all.php?name=SG) (Restaurants) reported for 2024 q4
(2025-02-26, After Market Close):
- Revenue +228.8% YoY (vs +137.3% in previous quarter and historical rate +53.3%)
- EBITDA margin -4.6% increased compared to -8.5% same period last year
- Net Debt increased by $36 mln over the past reporting period (1.4% of market cap)
- FCF (LTM) -$0.3 bln (negative), 13.3% of market cap
- EV/Sales multiple is 2.2x
At the opening of the session the share price went down -4.9% vs S&P500 +0.3%
------------------------------------------------
2025-02-27
#reports #SEMR
[Semrush Holdings, Inc.](https://eninvs.com/all.php?name=SEMR) (Software — Application) reported for 2024 q4
(2025-02-26, After Market Close):
- Revenue +24.1% YoY (vs +22.8% in previous quarter and historical rate +26.5%)
- EBITDA +225% YoY (vs 0.0% in previous quarter)
- EBITDA margin 12.6% increased compared to 4.8% same period last year
- Net Debt decreased by $4 mln over the past reporting period (0.2% of market cap)
- FCF (LTM) -$0 bln (negative), 0.4% of market cap
- EV/EBITDA multiple is 48.8x compared to historical level (75th percentile) of 109.4x
- EV/Sales multiple is 5.2x
At the opening of the session the share price went down -13.5% vs S&P500 +0.3%
------------------------------------------------
2025-02-27
#reports #SEE
[Sealed Air](https://eninvs.com/all.php?name=SEE) (Packaging manufacturer) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=180892)
(2025-02-25, Before Market Open):
- Revenue -0.4% YoY (vs -2.7% in previous quarter and historical rate -0.7%)
- EBITDA +0.8% YoY (vs +13.7% in previous quarter and historical rate -2.8%)
- EBITDA margin 19.5% increased compared to 19.3% same period last year
- Net Debt decreased by $113 mln over the past reporting period (2.3% of market cap)
- FCF (LTM) +$0.2 bln (positive), 3.9% of market cap
- EV/EBITDA multiple is 9.2x compared to historical level (75th percentile) of 10.3x
- EV/Sales multiple is 1.7x
At the opening of the session the share price went up +9.4% vs S&P500 -0.4%
------------------------------------------------
2025-02-27
#reports #SEAS
[SeaWorld Entertainment](https://eninvs.com/all.php?name=SEAS) (Theme park owner) reported for 2024 q4
(2023-11-08, Before Market Open):
- Revenue -1.3% YoY (vs -0.4% in previous quarter and historical rate +7.4%)
- EBITDA -7.8% YoY (vs +0.4% in previous quarter and historical rate +28.4%)
- EBITDA margin 30.7% decreased compared to 32.9% same period last year
- Net Debt decreased by $2.3 bln since the start of the year (79.6% of market cap)
- FCF (LTM) -$0 bln (negative), 1.6% of market cap
- EV/EBITDA multiple is 8.3x compared to historical level (75th percentile) of 9x
- EV/Sales multiple is 3x
At the opening of the session the share price went up +1.7%
------------------------------------------------
2025-02-27
#reports #SDGR
[Schrodinger/United States](https://eninvs.com/all.php?name=SDGR) (Software developer) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=180934)
(2025-02-26, After Market Close):
- Revenue -50% YoY (vs -18.6% in previous quarter and historical rate +1.5%)
- EBITDA margin -178.4% decreased compared to -35.1% same period last year
- Net Debt increased by $35 mln over the past reporting period (2.3% of market cap)
- FCF (LTM) -$0.1 bln (negative), 4.3% of market cap
- EV/Sales multiple is 10.9x
At the opening of the session the share price went neutrally vs S&P500 +0.3%
------------------------------------------------
2025-02-27
#reports #SCKT
[Socket Mobile](https://eninvs.com/all.php?name=SCKT) (Computer Hardware) reported for 2024 q4
(2025-02-25, After Market Close):
- Revenue +25% YoY (vs +33.3% in previous quarter and historical rate -3.5%)
- Net Debt decreased by $4 bln since the start of the year (46811.5% of market cap)
- EV/EBITDA multiple is 4016.6x compared to historical level (75th percentile) of 14x
- EV/Sales multiple is 211.4x
At the opening of the session the share price went down -3.3% vs S&P500 +0.2%
------------------------------------------------
2025-02-27
#reports #SBGI
[Sinclair Broadcast](https://eninvs.com/all.php?name=SBGI) (Broadcasting company) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=181018)
(2023-08-02, Before Market Open):
- Revenue +21.5% YoY (vs +19.6% in previous quarter and historical rate -13.5%)
- EBITDA margin 26.5% increased compared to -44.2% same period last year
- Net Debt decreased by $169 mln over the past reporting period (17.6% of market cap)
- EV/EBITDA multiple is 7.4x compared to historical level (75th percentile) of 1.2x
- EV/Sales multiple is 1.3x
------------------------------------------------
2025-02-27
#reports #SAM
[The Boston Beer Company](https://eninvs.com/all.php?name=SAM) (Alcoholic beverages supplier) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=181162)
(2025-02-25, After Market Close):
- Revenue -20.6% YoY (vs +19.3% in previous quarter and historical rate +0.1%)
- EBITDA margin -10.0% decreased compared to -1.0% same period last year
- Net Debt increased by $41 mln over the past reporting period (1.4% of market cap)
- FCF (LTM) +$0 bln (positive), 0.5% of market cap
- EV/EBITDA multiple is 16.5x compared to historical level (75th percentile) of 26.3x
- EV/Sales multiple is 1.4x
At the opening of the session the share price went up +0.3% vs S&P500 +0.2%
------------------------------------------------
2025-02-27
#reports #SAFT
[Safety Insurance](https://eninvs.com/all.php?name=SAFT) (Insurance — Property and Casualty) reported for 2024 q4
(2025-02-25, After Market Close):
- Revenue +11.2% YoY (vs +28.8% in previous quarter and historical rate +9.3%)
- Net Income -33.3% YoY (vs +1200.0% in previous quarter and historical rate -6.9%)
- Net Income margin 2.8% decreased compared to 4.7% same period last year
- P/E multiple is 15.7x compared to historical level (75th percentile) of 35.1x
- P/S multiple is 1x
- Price to book: 1.3x
At the opening of the session the share price went down -3.8% vs S&P500 +0.2%
------------------------------------------------
2025-02-27
#reports #RYTM
[Rhythm Pharmaceuticals](https://eninvs.com/all.php?name=RYTM) (Molecular drug manufacturer) reported for 2024 q4
(2025-02-26, Before Market Open):
- Revenue +75% YoY (vs +43.5% in previous quarter and historical rate +156.2%)
- EBITDA margin -78.6% increased compared to -137.5% same period last year
- Net Debt increased by $5 mln over the past reporting period (0.2% of market cap)
- FCF (LTM) -$0.5 bln (negative), 14.9% of market cap
- EV/Sales multiple is 26.8x
At the opening of the session the share price went up +0.8% vs S&P500 +0.2%
------------------------------------------------
2025-02-27
#reports #RXST
[RxSight, Inc.](https://eninvs.com/all.php?name=RXST) (Medical Devices) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=181040)
(2025-02-25, After Market Close):
- Revenue +37.9% YoY (vs +59.1% in previous quarter and historical rate +78.7%)
- EBITDA margin -20.0% increased compared to -34.5% same period last year
- Net Debt increased by $1 mln over the past reporting period (0.1% of market cap)
- FCF (LTM) +$0.1 bln (positive), 12.7% of market cap
- EV/Sales multiple is 4.1x
At the opening of the session the share price went down -6.1% vs S&P500 +0.2%
------------------------------------------------
2025-02-27
#reports #RVLV
[Revolve Group](https://eninvs.com/all.php?name=RVLV) (E-commerce fashion company) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=181112)
(2025-02-25, After Market Close):
- Revenue +14% YoY (vs +9.7% in previous quarter and historical rate +9.6%)
- EBITDA +225% YoY (vs +700.0% in previous quarter and historical rate +10.9%)
- EBITDA margin 4.4% increased compared to 1.6% same period last year
- Net Debt decreased by $6 mln over the past reporting period (0.3% of market cap)
- FCF (LTM) +$0 bln (positive), 0.7% of market cap
- EV/EBITDA multiple is 29x compared to historical level (75th percentile) of 41.2x
- EV/Sales multiple is 1.5x
At the opening of the session the share price went down -3.9% vs S&P500 +0.2%
------------------------------------------------
2025-02-27
#reports #RRGB
[Red Robin Gourmet Burgers](https://eninvs.com/all.php?name=RRGB) (Restaurant chain owner) reported for 2024 q4
(2025-02-26, After Market Close):
- Revenue -7.8% YoY (vs -1.1% in previous quarter and historical rate +7.6%)
- EBITDA -450% YoY (vs -100.0% in previous quarter and historical rate -6.7%)
- EBITDA margin -7.4% decreased compared to 1.9% same period last year
- Net Debt decreased by $17 mln over the past reporting period (23.9% of market cap)
- FCF (LTM) +$0 bln (positive), 30.9% of market cap
- EV/Sales multiple is 0.5x
------------------------------------------------
2025-02-27
#reports #ROOT
[Root, Inc.](https://eninvs.com/all.php?name=ROOT) (Insurance — Property and Casualty) reported for [2024 q4](https://eninvs.com/press_release.php?ticker=ROOT&q=2024 q4&id=821933)
(2025-02-26, After Market Close):
- Revenue +67.7% YoY (vs +166.1% in previous quarter and historical rate +67.3%)
- Net Income margin 6.7% increased compared to -12.3% same period last year
- P/S multiple is 1.2x
- Price to book: 7.7x
At the opening of the session the share price went up +23.9% vs S&P500 +0.3%
------------------------------------------------
2025-02-27
#reports #RLJ
[RLJ Lodging Trust](https://eninvs.com/all.php?name=RLJ) (REIT — Hotel and Motel) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=180936)
(2025-02-25, After Market Close):
- Revenue +3.1% YoY (vs +3.6% in previous quarter and historical rate +24.8%)
- EBITDA -73.9% YoY (vs +7.6% in previous quarter and historical rate +66.2%)
- EBITDA margin 8.8% decreased compared to 34.7% same period last year
- Net Debt decreased by $2.4 bln since the start of the year (154.8% of market cap)
- FCF (LTM) -$0.2 bln (negative), 10.2% of market cap
- EV/EBITDA multiple is 13.7x compared to historical level (75th percentile) of 27.9x
- EV/Sales multiple is 2.8x
At the opening of the session the share price went up +0.4% vs S&P500 +0.2%
------------------------------------------------
2025-02-27
#reports #RCKY
[Rocky Brands](https://eninvs.com/all.php?name=RCKY) (Footwear and Accessories) reported for 2024 q4
(2025-02-25, After Market Close):
- Revenue +1.6% YoY (vs -8.7% in previous quarter and historical rate +0.7%)
- EBITDA -42.9% YoY (vs -22.2% in previous quarter and historical rate +27.7%)
- EBITDA margin 6.3% decreased compared to 11.1% same period last year
- Net Debt decreased by $22 mln over the past reporting period (14.3% of market cap)
- FCF (LTM) +$0 bln (positive), 16.3% of market cap
- EV/EBITDA multiple is 7.4x compared to historical level (75th percentile) of 10.7x
- EV/Sales multiple is 0.6x
At the opening of the session the share price went down -2.4% vs S&P500 +0.2%
------------------------------------------------
2025-02-27
#reports #QUIK
[QuickLogic Corporation](https://eninvs.com/all.php?name=QUIK) (Semiconductors) reported for 2024 q4
(2025-02-25, After Market Close):
- Revenue -14.3% YoY (vs -42.9% in previous quarter and historical rate +28.0%)
- EBITDA -50% YoY (vs -150.0% in previous quarter)
- EBITDA margin 33.3% decreased compared to 57.1% same period last year
- Net Debt decreased by $2 mln over the past reporting period (1.9% of market cap)
- FCF (LTM) -$0 bln (negative), 7.5% of market cap
- EV/Sales multiple is 5.4x
At the opening of the session the share price went up +6.2% vs S&P500 +0.2%
------------------------------------------------
2025-02-27
#reports #PSTG
[Pure Storage](https://eninvs.com/all.php?name=PSTG) (IT services provider) reported for 2024 q4
(2025-02-26, After Market Close):
- Revenue +11.4% YoY (vs +8.9% in previous quarter and historical rate +11.4%)
- EBITDA -20% YoY (vs -19.8% in previous quarter and historical rate +57.8%)
- EBITDA margin 8.2% decreased compared to 11.4% same period last year
- Net Debt increased by $1.4 bln since the start of the year (7.6% of market cap)
- FCF (LTM) -$0.1 bln (negative), 0.6% of market cap
- EV/EBITDA multiple is 80.9x compared to historical level (75th percentile) of 83.5x
- EV/Sales multiple is 5.2x
------------------------------------------------
2025-02-27
#reports #PRCT
[PROCEPT BioRobotics Corporation](https://eninvs.com/all.php?name=PRCT) (Medical Devices) reported for 2024 q4
(2025-02-25, After Market Close):
- Revenue +54.5% YoY (vs +65.7% in previous quarter and historical rate +79.9%)
- EBITDA margin -64.7% increased compared to -122.7% same period last year
- Net Debt decreased by $137 mln over the past reporting period (4.5% of market cap)
- FCF (LTM) -$0.1 bln (negative), 2.1% of market cap
- EV/Sales multiple is 12.4x
At the opening of the session the share price went up +4.5% vs S&P500 +0.2%
------------------------------------------------
2025-02-27
#reports #PNFP
[Pinnacle Financial Partners](https://eninvs.com/all.php?name=PNFP) (Banking service provider) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=181041)
(2025-01-21, After Market Close):
- Revenue +14.8% YoY (vs +11.0% in previous quarter and historical rate -1.1%)
- Net Income +58.9% YoY (vs +10.5% in previous quarter and historical rate +4.4%)
- Net Income margin 41.5% increased compared to 30.0% same period last year
- P/E multiple is 18.3x compared to historical level (75th percentile) of 12.5x
- P/S multiple is 6.4x
- Price to book: 1.4x
At the opening of the session the share price went up +2.5% vs S&P500 +0.6%
------------------------------------------------
2025-02-27
#reports #PLYA
[Playa Hotels & Resorts NV](https://eninvs.com/all.php?name=PLYA) (Resorts and Casinos) reported for 2024 q4
(2025-02-25, After Market Close):
- Revenue -9.9% YoY (vs -13.6% in previous quarter and historical rate +28.8%)
- EBITDA -5.5% YoY (vs -2.8% in previous quarter and historical rate +40.8%)
- EBITDA margin 23.7% increased compared to 22.6% same period last year
- Net Debt decreased by $866 mln over the past reporting period (50.7% of market cap)
- EV/EBITDA multiple is 10.2x compared to historical level (75th percentile) of 9.8x
- EV/Sales multiple is 2.7x
At the opening of the session the share price went neutrally vs S&P500 +0.2%
------------------------------------------------
2025-02-27
#reports #PLNT
[Planet Fitness](https://eninvs.com/all.php?name=PLNT) ( Fitness centers owner) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=181101)
(2025-02-25, Before Market Open):
- Revenue +19.3% YoY (vs +5.0% in previous quarter and historical rate +28.7%)
- EBITDA +17.1% YoY (vs +10.9% in previous quarter and historical rate +59.8%)
- EBITDA margin 38.2% decreased compared to 38.9% same period last year
- Net Debt decreased by $3 mln over the past reporting period (0.0% of market cap)
- FCF (LTM) -$0.1 bln (negative), 1.5% of market cap
- EV/EBITDA multiple is 19.5x compared to historical level (75th percentile) of 31.7x
- EV/Sales multiple is 8x
At the opening of the session the share price went down -7.0% vs S&P500 -0.4%
------------------------------------------------
2025-02-27
#reports #PLAB
[Photronics](https://eninvs.com/all.php?name=PLAB) (Semiconductor Equipment and Materials) reported for 2024 q4
(2025-02-26, Before Market Open):
- Revenue -1.9% YoY (vs +281.9% in previous quarter and historical rate +24.6%)
- EBITDA -5.2% YoY (vs +237.8% in previous quarter and historical rate +33.4%)
- EBITDA margin 34.4% decreased compared to 35.6% same period last year
- Net Debt decreased by $52 mln over the past reporting period (4.0% of market cap)
- FCF (LTM) +$0.1 bln (positive), 8.8% of market cap
- EV/EBITDA multiple is 1.9x compared to historical level (75th percentile) of 4.7x
- EV/Sales multiple is 0.7x
At the opening of the session the share price went up +0.5% vs S&P500 +0.2%
------------------------------------------------
2025-02-27
#reports #PEG
[Public Service Enterprise](https://eninvs.com/all.php?name=PEG) (Energy provider) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=181143)
(2025-02-25, Before Market Open):
- Revenue -5.4% YoY (vs 0.0% in previous quarter and historical rate +6.5%)
- EBITDA -23.5% YoY (vs +12.2% in previous quarter and historical rate +45.4%)
- EBITDA margin 30.5% decreased compared to 37.8% same period last year
- EV/EBITDA multiple is 11.7x compared to historical level (75th percentile) of 14.2x
- EV/Sales multiple is 3.7x
At the opening of the session the share price went up +1.0% vs S&P500 -0.4%
------------------------------------------------
2025-02-27
#reports #PEB
[Pebblebrook Hotel Trust](https://eninvs.com/all.php?name=PEB) (REIT — Hotel and Motel) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=180931)
(2025-02-26, After Market Close):
- Revenue +1.2% YoY (vs +2.3% in previous quarter and historical rate +35.9%)
- EBITDA -22.2% YoY (vs +183.8% in previous quarter and historical rate +34.4%)
- EBITDA margin 10.4% decreased compared to 13.5% same period last year
- EV/EBITDA multiple is 12.2x compared to historical level (75th percentile) of 15.5x
- EV/Sales multiple is 2.6x
------------------------------------------------
2025-02-27
#reports #ONTF
[ON24, Inc.](https://eninvs.com/all.php?name=ONTF) (Software — Application) reported for 2024 q4
(2025-02-25, After Market Close):
- Revenue -5.1% YoY (vs -7.7% in previous quarter and historical rate -9.9%)
- EBITDA margin -18.9% decreased compared to -17.9% same period last year
- Net Debt increased by $6 mln over the past reporting period (2.2% of market cap)
- FCF (LTM) +$0 bln (positive), 4.4% of market cap
- EV/Sales multiple is 0.6x
At the opening of the session the share price went down -1.3% vs S&P500 +0.2%
------------------------------------------------
2025-02-27
#reports #OLO
[Olo Inc.](https://eninvs.com/all.php?name=OLO) (Software — Application) reported for 2024 q4
(2025-02-25, After Market Close):
- Revenue +20.6% YoY (vs +24.1% in previous quarter and historical rate +24.3%)
- EBITDA margin 3.9% increased compared to -30.2% same period last year
- Net Debt decreased by $12 mln over the past reporting period (1.1% of market cap)
- FCF (LTM) +$0 bln (positive), 0.4% of market cap
- EV/Sales multiple is 2.7x
At the opening of the session the share price went up +8.8% vs S&P500 +0.2%
------------------------------------------------
2025-02-27
#reports #OFIX
[Orthofix Medical](https://eninvs.com/all.php?name=OFIX) (Medical equipment manufacturer) reported for 2024 q4
(2025-02-25, Before Market Open):
- Revenue +8% YoY (vs +7.1% in previous quarter and historical rate +22.9%)
- EBITDA margin -2.8% increased compared to -7.5% same period last year
- EV/Sales multiple is 0.8x
At the opening of the session the share price went up +4.4% vs S&P500 -0.4%
------------------------------------------------
2025-02-27
#reports #ODP
[Office Depot](https://eninvs.com/all.php?name=ODP) (Specialty Retail) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=181000)
(2025-02-26, Before Market Open):
- Revenue -10.2% YoY (vs -11.4% in previous quarter and historical rate -7.5%)
- EBITDA margin 4.4% increased compared to -0.2% same period last year
- Net Debt increased by $26 mln over the past reporting period (3.6% of market cap)
- FCF (LTM) -$0.2 bln (negative), 34.0% of market cap
- EV/EBITDA multiple is 6.2x compared to historical level (75th percentile) of 10.6x
- EV/Sales multiple is 0.2x
At the opening of the session the share price went down -9.7% vs S&P500 +0.2%
------------------------------------------------
2025-02-27
#reports #NSA
[National Storage Affiliates Trust](https://eninvs.com/all.php?name=NSA) (Real estate investment trust ) reported for 2024 q4
(2025-02-26, After Market Close):
- Revenue -11.6% YoY (vs -11.4% in previous quarter and historical rate +11.8%)
- EBITDA -13.5% YoY (vs -12.1% in previous quarter and historical rate +33.5%)
- EBITDA margin 64.2% decreased compared to 65.6% same period last year
- EV/EBITDA multiple is 14.7x compared to historical level (75th percentile) of 25.3x
- EV/Sales multiple is 9.3x
------------------------------------------------
2025-02-27
#reports #NRG
[NRG Energy](https://eninvs.com/all.php?name=NRG) (Energy services provider) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=180894)
(2025-02-26, Before Market Open):
- Revenue +0.2% YoY (vs -9.1% in previous quarter and historical rate +6.7%)
- EBITDA -9.9% YoY (vs -152.9% in previous quarter and historical rate +32.2%)
- EBITDA margin 15.2% decreased compared to 16.9% same period last year
- Net Debt decreased by $362 mln over the past reporting period (1.3% of market cap)
- FCF (LTM) +$0.4 bln (positive), 1.4% of market cap
- EV/EBITDA multiple is 11x compared to historical level (75th percentile) of 9.3x
- EV/Sales multiple is 1.3x
At the opening of the session the share price went up +2.4% vs S&P500 +0.2%
------------------------------------------------
2025-02-27
#reports #NR
[Newpark Resources](https://eninvs.com/all.php?name=NR) (Oil and Gas Equipment and Services) reported for 2024 q4
(2024-11-07, After Market Close):
- Revenue -65.5% YoY (vs -77.8% in previous quarter and historical rate -4.8%)
- EBITDA +41.7% YoY (vs -61.9% in previous quarter and historical rate +30.2%)
- EBITDA margin 29.3% increased compared to 7.1% same period last year
- Net Debt increased by $20 mln over the past reporting period (3.2% of market cap)
- FCF (LTM) +$0.1 bln (positive), 11.8% of market cap
- EV/EBITDA multiple is 9.5x compared to historical level (75th percentile) of 14.9x
- EV/Sales multiple is 1.4x
At the opening of the session the share price went down -6.1% vs S&P500 -0.1%
------------------------------------------------
2025-02-27
#reports #NOVT
[Novanta](https://eninvs.com/all.php?name=NOVT) (Scientific and Technical Instruments) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=181037)
(2025-02-25, Before Market Open):
- Revenue +12.3% YoY (vs +9.9% in previous quarter and historical rate +10.8%)
- EBITDA +24.2% YoY (vs +11.9% in previous quarter and historical rate +14.5%)
- EBITDA margin 17.2% increased compared to 15.6% same period last year
- Net Debt decreased by $55 mln over the past reporting period (1.0% of market cap)
- FCF (LTM) -$0.1 bln (negative), 2.3% of market cap
- EV/EBITDA multiple is 34.3x compared to historical level (75th percentile) of 42x
- EV/Sales multiple is 6x
At the opening of the session the share price went up +0.7% vs S&P500 -0.4%
------------------------------------------------
2025-02-27
#reports #MQ
[Marqeta, Inc.](https://eninvs.com/all.php?name=MQ) (Software — Infrastructure) reported for 2024 q4
(2025-02-26, After Market Close):
- Revenue +14.3% YoY (vs +17.4% in previous quarter and historical rate +3.6%)
- EBITDA margin -23.5% increased compared to -44.5% same period last year
- EV/EBITDA multiple is 17.9x compared to historical level (75th percentile) of 20.9x
- EV/Sales multiple is 1.4x
At the opening of the session the share price went up +23.9% vs S&P500 +0.3%
------------------------------------------------
2025-02-27
#reports #MNKD
[MannKind Corporation](https://eninvs.com/all.php?name=MNKD) (Biotechnology) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=181014)
(2025-02-26, After Market Close):
- Revenue +32.8% YoY (vs +37.3% in previous quarter and historical rate +69.3%)
- EBITDA +190% YoY (vs +160.0% in previous quarter and historical rate +112.5%)
- EBITDA margin 37.7% increased compared to 17.2% same period last year
- Net Debt decreased by $139 mln over the past reporting period (10.1% of market cap)
- FCF (LTM) -$0 bln (negative), 0.8% of market cap
- EV/EBITDA multiple is 15.8x compared to historical level (75th percentile) of 40.1x
- EV/Sales multiple is 4.3x
------------------------------------------------
2025-02-27
#reports #MMSI
[Merit Medical Systems](https://eninvs.com/all.php?name=MMSI) (Medical instrument manufacturer) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=181145)
(2025-02-25, After Market Close):
- Revenue +9.2% YoY (vs +7.9% in previous quarter and historical rate +8.1%)
- EBITDA +14% YoY (vs -17.9% in previous quarter and historical rate +25.3%)
- EBITDA margin 18.3% increased compared to 17.5% same period last year
- Net Debt increased by $121 mln over the past reporting period (2.1% of market cap)
- FCF (LTM) +$0 bln (positive), 0.1% of market cap
- EV/EBITDA multiple is 24.2x compared to historical level (75th percentile) of 25.6x
- EV/Sales multiple is 4.6x
At the opening of the session the share price went down -3.5% vs S&P500 +0.2%
------------------------------------------------
2025-02-27
#reports #MGPI
[MGP Ingredients](https://eninvs.com/all.php?name=MGPI) (Liquor manufacturer) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=181006)
(2025-02-26, Before Market Open):
- Revenue -15.8% YoY (vs -24.1% in previous quarter and historical rate +7.1%)
- EBITDA -138.8% YoY (vs +34.6% in previous quarter and historical rate +0.4%)
- EBITDA margin -10.5% decreased compared to 22.8% same period last year
- Net Debt increased by $30 mln over the past reporting period (4.2% of market cap)
- FCF (LTM) +$0 bln (positive), 1.4% of market cap
- EV/EBITDA multiple is 10.6x compared to historical level (75th percentile) of 13.8x
- EV/Sales multiple is 1.4x
At the opening of the session the share price went down -3.1% vs S&P500 +0.2%
------------------------------------------------
2025-02-27
#reports #MEG
[Montrose Environmental Group](https://eninvs.com/all.php?name=MEG) (Waste Management) reported for 2024 q4
(2025-02-26, After Market Close):
- Revenue +13.9% YoY (vs +6.5% in previous quarter and historical rate +8.7%)
- EBITDA -333.3% YoY (vs +50.0% in previous quarter and historical rate +0.1%)
- EBITDA margin -3.7% decreased compared to 1.8% same period last year
- Net Debt decreased by $42 mln over the past reporting period (7.0% of market cap)
- FCF (LTM) -$0.3 bln (negative), 54.8% of market cap
- EV/EBITDA multiple is 110.4x compared to historical level (75th percentile) of 358.7x
- EV/Sales multiple is 2.7x
------------------------------------------------
2025-02-27
#reports #MDXG
[MiMedx Group](https://eninvs.com/all.php?name=MDXG) (Medical Devices) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=180923)
(2025-02-26, After Market Close):
- Revenue +6.9% YoY (vs +2.4% in previous quarter and historical rate +10.9%)
- EBITDA -62.1% YoY (vs 0.0% in previous quarter and historical rate +61.5%)
- EBITDA margin 11.8% decreased compared to 33.3% same period last year
- Net Debt decreased by $16 mln over the past reporting period (1.4% of market cap)
- FCF (LTM) +$0.3 bln (positive), 23.4% of market cap
- EV/EBITDA multiple is 22.3x compared to historical level (75th percentile) of 29x
- EV/Sales multiple is 3.1x
------------------------------------------------
2025-02-27
#reports #MATX
[Matson](https://eninvs.com/all.php?name=MATX) (Logistic services provider) reported for 2024 q4
(2025-02-25, After Market Close):
- Revenue +12.8% YoY (vs +16.2% in previous quarter and historical rate +0.9%)
- EBITDA +66.1% YoY (vs +67.3% in previous quarter and historical rate +18.0%)
- EBITDA margin 20.9% increased compared to 14.2% same period last year
- Net Debt decreased by $263 mln over the past reporting period (4.5% of market cap)
- FCF (LTM) -$0 bln (negative), 0.8% of market cap
- EV/EBITDA multiple is 8.5x compared to historical level (75th percentile) of 10x
- EV/Sales multiple is 1.7x
At the opening of the session the share price went up +4.8% vs S&P500 +0.2%
------------------------------------------------
2025-02-27
#reports #LZ
[LegalZoom.com, Inc.](https://eninvs.com/all.php?name=LZ) (Specialty Business Services) reported for 2024 q4
(2025-02-26, After Market Close):
- Revenue +1.9% YoY (vs +1.2% in previous quarter and historical rate +5.9%)
- Net Income +85.7% YoY (vs +37.5% in previous quarter and historical rate +86.9%)
- Net Income margin 8.0% increased compared to 4.4% same period last year
- P/E multiple is 62.4x compared to historical level (75th percentile) of 137.1x
- P/S multiple is 2.4x
- Price to book: 27.7x
At the opening of the session the share price went up +12.4% vs S&P500 +0.3%
------------------------------------------------
2025-02-27
#reports #LXU
[LSB Industries](https://eninvs.com/all.php?name=LXU) (Chemicals) reported for [2024 q4](https://eninvs.com/press_release.php?ticker=LXU&q=2024 q4&id=820259)
(2025-02-26, After Market Close):
- Revenue +1.5% YoY (vs -4.4% in previous quarter and historical rate +8.2%)
- EBITDA margin -20.0% decreased compared to -12.8% same period last year
- Net Debt increased by $17 mln over the past reporting period (2.5% of market cap)
- FCF (LTM) -$0 bln (negative), 1.9% of market cap
- EV/EBITDA multiple is 168.5x compared to historical level (75th percentile) of 16.1x
- EV/Sales multiple is 1.9x
------------------------------------------------
2025-02-27
#reports #LNTH
[Lantheus](https://eninvs.com/all.php?name=LNTH) (Medicine equipment developer) reported for 2024 q4
(2025-02-26, Before Market Open):
- Revenue +10.5% YoY (vs +18.4% in previous quarter and historical rate +59.5%)
- EBITDA -16.4% YoY (vs +16.5% in previous quarter and historical rate +84.6%)
- EBITDA margin 31.2% decreased compared to 41.2% same period last year
- Net Debt decreased by $46 mln over the past reporting period (0.7% of market cap)
- FCF (LTM) +$0.2 bln (positive), 3.0% of market cap
- EV/EBITDA multiple is 12x compared to historical level (75th percentile) of 65.1x
- EV/Sales multiple is 4x
At the opening of the session the share price went up +1.2% vs S&P500 +0.2%
------------------------------------------------
2025-02-27
#reports #LIVN
[LivaNova](https://eninvs.com/all.php?name=LIVN) (Medical Devices) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=181102)
(2025-02-25, Before Market Open):
- Revenue +201.6% YoY (vs +11.2% in previous quarter and historical rate +23.1%)
- EBITDA margin 9.9% increased compared to -24.2% same period last year
- Net Debt decreased by $106 mln over the past reporting period (4.8% of market cap)
- EV/EBITDA multiple is 13x compared to historical level (75th percentile) of 368.4x
- EV/Sales multiple is 1.3x
At the opening of the session the share price went down -5.7% vs S&P500 -0.4%
------------------------------------------------
2025-02-27
#reports #LGIH
[LGI Homes](https://eninvs.com/all.php?name=LGIH) (Building services provider) reported for 2024 q4
(2025-02-25, Before Market Open):
- Revenue -8.4% YoY (vs +5.5% in previous quarter and historical rate -9.3%)
- EBITDA -23.3% YoY (vs -2.4% in previous quarter and historical rate -21.1%)
- EBITDA margin 8.3% decreased compared to 9.9% same period last year
- Net Debt decreased by $1.5 bln since the start of the year (83.4% of market cap)
- EV/EBITDA multiple is 15x compared to historical level (75th percentile) of 13.1x
- EV/Sales multiple is 1.5x
At the opening of the session the share price went up +9.4% vs S&P500 -0.4%
------------------------------------------------
2025-02-27
#reports #KTOS
[Kratos](https://eninvs.com/all.php?name=KTOS) (Security services provider) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=180903)
(2025-02-26, After Market Close):
- Revenue +3.3% YoY (vs +0.4% in previous quarter and historical rate +12.1%)
- EBITDA -87.5% YoY (vs -28.6% in previous quarter and historical rate +38.2%)
- EBITDA margin 1.1% decreased compared to 8.8% same period last year
- Net Debt decreased by $47 mln over the past reporting period (1.5% of market cap)
- EV/EBITDA multiple is 58x compared to historical level (75th percentile) of 49.6x
- EV/Sales multiple is 2.7x
At the opening of the session the share price went up +0.5% vs S&P500 +0.3%
------------------------------------------------
2025-02-27
#reports #KTB
[Kontoor Brands](https://eninvs.com/all.php?name=KTB) (Clothes manufacturer) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=181113)
(2025-02-25, Before Market Open):
- Revenue +189.1% YoY (vs +2.3% in previous quarter and historical rate +17.7%)
- EBITDA +216.5% YoY (vs +18.6% in previous quarter and historical rate +35.4%)
- EBITDA margin 13.9% increased compared to 12.7% same period last year
- Net Debt decreased by $533 mln over the past reporting period (14.0% of market cap)
- FCF (LTM) +$0.1 bln (positive), 2.5% of market cap
- EV/EBITDA multiple is 8.2x compared to historical level (75th percentile) of 13.8x
- EV/Sales multiple is 1.1x
At the opening of the session the share price went down -5.1% vs S&P500 -0.4%
------------------------------------------------
2025-02-27
#reports #KNSA
[Kiniksa Pharmaceuticals](https://eninvs.com/all.php?name=KNSA) (Biotechnology) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=181110)
(2025-02-25, Before Market Open):
- Revenue +48.2% YoY (vs +67.2% in previous quarter and historical rate +104.5%)
- EBITDA margin 212.2% increased compared to 1.2% same period last year
- Net Debt decreased by $21 mln over the past reporting period (1.5% of market cap)
- EV/EBITDA multiple is 5x compared to historical level (75th percentile) of 47.4x
- EV/Sales multiple is 2.8x
At the opening of the session the share price went down -3.1% vs S&P500 -0.4%
------------------------------------------------
2025-02-27
#reports #KEYS
[Keysight Technologies](https://eninvs.com/all.php?name=KEYS) (Test equipment manufacturer) reported for 2024 q4
(2025-02-25, After Market Close):
- Revenue +3.1% YoY (vs -1.8% in previous quarter and historical rate +0.4%)
- EBITDA -1.7% YoY (vs -18.8% in previous quarter and historical rate -6.7%)
- EBITDA margin 21.9% decreased compared to 23.0% same period last year
- Net Debt decreased by $274 mln over the past reporting period (0.9% of market cap)
- FCF (LTM) +$0.4 bln (positive), 1.5% of market cap
- EV/EBITDA multiple is 26.2x compared to historical level (75th percentile) of 20x
- EV/Sales multiple is 5.7x
At the opening of the session the share price went down -6.1% vs S&P500 +0.2%
------------------------------------------------
2025-02-27
#reports #JAZZ
[Jazz Pharmaceuticals](https://eninvs.com/all.php?name=JAZZ) (Biotechnology) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=180916)
(2025-02-25, After Market Close):
- Revenue +7.5% YoY (vs +8.5% in previous quarter and historical rate +10.2%)
- EBITDA +23.3% YoY (vs +48.9% in previous quarter and historical rate +22.5%)
- EBITDA margin 33.1% increased compared to 28.9% same period last year
- Net Debt increased by $3.2 bln since the start of the year (35.0% of market cap)
- FCF (LTM) +$0.4 bln (positive), 3.9% of market cap
- EV/EBITDA multiple is 12.3x compared to historical level (75th percentile) of 21.5x
- EV/Sales multiple is 3x
At the opening of the session the share price went up +0.6% vs S&P500 +0.2%
------------------------------------------------
2025-02-27
#reports #ITRI
[Itron](https://eninvs.com/all.php?name=ITRI) (Service provider for housing and communal services) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=181142)
(2025-02-25, Before Market Open):
- Revenue +6.2% YoY (vs +9.6% in previous quarter and historical rate +8.2%)
- EBITDA -7.4% YoY (vs +25.0% in previous quarter and historical rate +53.5%)
- EBITDA margin 10.3% decreased compared to 11.8% same period last year
- Net Debt decreased by $71 mln over the past reporting period (1.5% of market cap)
- FCF (LTM) -$0.1 bln (negative), 2.1% of market cap
- EV/EBITDA multiple is 15.8x compared to historical level (75th percentile) of 39.5x
- EV/Sales multiple is 2.1x
At the opening of the session the share price went up +10.2% vs S&P500 -0.4%
------------------------------------------------
2025-02-27
#reports #INVA
[Innoviva](https://eninvs.com/all.php?name=INVA) (Biotechnology) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=180905)
(2025-02-26, After Market Close):
- Revenue +7% YoY (vs +34.3% in previous quarter and historical rate -0.3%)
- EBITDA -91% YoY (vs -86.8% in previous quarter and historical rate +3.9%)
- EBITDA margin 31.5% decreased compared to 373.3% same period last year
- Net Debt decreased by $41 mln over the past reporting period (3.7% of market cap)
- FCF (LTM) +$0.2 bln (positive), 15.5% of market cap
- EV/EBITDA multiple is 20.1x compared to historical level (75th percentile) of 4.8x
- EV/Sales multiple is 3.5x
------------------------------------------------
2025-02-27
#reports #INTU
[Intuit](https://eninvs.com/all.php?name=INTU) (Software developer) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=181154)
(2025-02-25, After Market Close):
- Revenue +17% YoY (vs +10.2% in previous quarter and historical rate +14.5%)
- EBITDA +55% YoY (vs -7.4% in previous quarter and historical rate -11.5%)
- EBITDA margin 17.1% increased compared to 12.9% same period last year
- Net Debt increased by $528 mln over the past reporting period (0.3% of market cap)
- FCF (LTM) +$0.9 bln (positive), 0.5% of market cap
- EV/EBITDA multiple is 43.8x compared to historical level (75th percentile) of 47x
- EV/Sales multiple is 10.5x
At the opening of the session the share price went up +14.4% vs S&P500 +0.2%
------------------------------------------------
2025-02-27
#reports #INGN
[Inogen](https://eninvs.com/all.php?name=INGN) (Medical products manufacturer) reported for 2024 q4
(2025-02-25, After Market Close):
- Revenue +5.3% YoY (vs +6.0% in previous quarter and historical rate -1.2%)
- EBITDA margin -7.5% increased compared to -31.6% same period last year
- Net Debt increased by $7 mln over the past reporting period (3.8% of market cap)
- FCF (LTM) -$0 bln (negative), 3.2% of market cap
- EV/Sales multiple is 0.3x
At the opening of the session the share price went up +25.4% vs S&P500 +0.2%
------------------------------------------------
2025-02-27
#reports #IART
[Integra LifeSciences](https://eninvs.com/all.php?name=IART) (Health care provider) reported for 2024 q4
(2025-02-25, Before Market Open):
- Revenue +11.6% YoY (vs -0.3% in previous quarter and historical rate +1.5%)
- EBITDA -1.4% YoY (vs -55.6% in previous quarter and historical rate -19.1%)
- EBITDA margin 16.0% decreased compared to 18.1% same period last year
- Net Debt decreased by $884 mln over the past reporting period (49.0% of market cap)
- FCF (LTM) -$0 bln (negative), 0.3% of market cap
- EV/EBITDA multiple is 16.7x compared to historical level (75th percentile) of 15x
- EV/Sales multiple is 1.7x
At the opening of the session the share price went down -2.5% vs S&P500 -0.4%
------------------------------------------------
2025-02-27
#reports #HY
[Hyster-Yale Materials Handling](https://eninvs.com/all.php?name=HY) (Loaders and spare parts manufacturer) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=181045)
(2025-02-25, After Market Close):
- Revenue +4% YoY (vs +1.5% in previous quarter and historical rate +12.1%)
- EBITDA -23.3% YoY (vs -35.7% in previous quarter and historical rate +55.2%)
- EBITDA margin 4.3% decreased compared to 5.8% same period last year
- Net Debt increased by $363 mln over the past reporting period (40.3% of market cap)
- FCF (LTM) -$0 bln (negative), 2.2% of market cap
- EV/EBITDA multiple is 4.3x compared to historical level (75th percentile) of 8.5x
- EV/Sales multiple is 0.3x
At the opening of the session the share price went up +1.0% vs S&P500 +0.2%
------------------------------------------------
2025-02-27
#reports #HURN
[Huron Consulting](https://eninvs.com/all.php?name=HURN) (Financial and operations advisor) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=181067)
(2025-02-25, After Market Close):
- Revenue +226.9% YoY (vs +3.0% in previous quarter and historical rate +33.9%)
- EBITDA +536.4% YoY (vs +30.2% in previous quarter and historical rate +64.0%)
- EBITDA margin 12.2% increased compared to 6.3% same period last year
- Net Debt decreased by $469 mln over the past reporting period (16.8% of market cap)
- FCF (LTM) +$0.1 bln (positive), 4.8% of market cap
- EV/EBITDA multiple is 10.7x compared to historical level (75th percentile) of 16.1x
- EV/Sales multiple is 1.4x
At the opening of the session the share price went up +7.1% vs S&P500 +0.2%
------------------------------------------------
2025-02-27
#reports #HNST
[The Honest Company, Inc.](https://eninvs.com/all.php?name=HNST) (Specialty Retail) reported for 2024 q4
(2025-02-26, After Market Close):
- Revenue +11.1% YoY (vs +15.1% in previous quarter and historical rate +6.1%)
- EBITDA +600% YoY (vs +1300.0% in previous quarter)
- EBITDA margin 14.0% increased compared to 2.2% same period last year
- Net Debt decreased by $24 mln over the past reporting period (4.2% of market cap)
- FCF (LTM) +$0 bln (positive), 4.7% of market cap
- EV/EBITDA multiple is 17.7x compared to historical level (75th percentile) of 53.2x
- EV/Sales multiple is 1.3x
At the opening of the session the share price went down -15.1% vs S&P500 +0.3%
------------------------------------------------
2025-02-27
#reports #HCAT
[Health Catalyst](https://eninvs.com/all.php?name=HCAT) (Software provider) reported for 2024 q4
(2025-02-26, After Market Close):
- Revenue +6.7% YoY (vs +2.7% in previous quarter and historical rate +8.3%)
- EBITDA margin -8.8% increased compared to -44.0% same period last year
- Net Debt increased by $33 mln over the past reporting period (11.1% of market cap)
- FCF (LTM) -$0 bln (negative), 14.7% of market cap
- EV/Sales multiple is 1x
------------------------------------------------
2025-02-27
#reports #HBB
[Hamilton Beach Brands Company](https://eninvs.com/all.php?name=HBB) (Furnishings, Fixtures and Appliances) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=180961)
(2025-02-26, After Market Close):
- Revenue +3.4% YoY (vs +1.9% in previous quarter and historical rate -0.7%)
- EBITDA -3.8% YoY (vs -20.0% in previous quarter and historical rate +50.7%)
- EBITDA margin 11.7% decreased compared to 12.6% same period last year
- Net Debt increased by $49 mln over the past reporting period (19.8% of market cap)
- EV/EBITDA multiple is 6.2x compared to historical level (75th percentile) of 11x
- EV/Sales multiple is 0.5x
------------------------------------------------
2025-02-27
#reports #GIC
[Global Industrial Company](https://eninvs.com/all.php?name=GIC) (Industrial Distribution) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=181020)
(2025-02-25, After Market Close):
- Revenue -5.6% YoY (vs -3.7% in previous quarter and historical rate +7.8%)
- EBITDA -30.4% YoY (vs -20.0% in previous quarter and historical rate -1.0%)
- EBITDA margin 5.3% decreased compared to 7.2% same period last year
- Net Debt decreased by $8 mln over the past reporting period (0.9% of market cap)
- FCF (LTM) +$0 bln (positive), 1.5% of market cap
- EV/EBITDA multiple is 11x compared to historical level (75th percentile) of 13.7x
- EV/Sales multiple is 0.7x
At the opening of the session the share price went up +0.2% vs S&P500 +0.2%
------------------------------------------------
2025-02-27
#reports #GHC
[Graham Company](https://eninvs.com/all.php?name=GHC) (Education cervices provider) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=180900)
(2025-02-24, Before Market Open):
- Revenue +310.5% YoY (vs +218.8% in previous quarter and historical rate +55.6%)
- EBITDA +630% YoY (vs -30.5% in previous quarter and historical rate +15.6%)
- EBITDA margin 1.5% increased compared to 0.9% same period last year
- Net Debt decreased by $329 mln over the past reporting period (6.9% of market cap)
- FCF (LTM) +$0.1 bln (positive), 3.1% of market cap
- EV/EBITDA multiple is 9.7x compared to historical level (75th percentile) of 9x
- EV/Sales multiple is 0.4x
At the opening of the session the share price went down -0.5% vs S&P500 +0.2%
------------------------------------------------
2025-02-27
#reports #FWRD
[Forward Air](https://eninvs.com/all.php?name=FWRD) (Transportation services provider) reported for 2024 q4
(2025-02-26, After Market Close):
- Revenue +87.3% YoY (vs +58.8% in previous quarter and historical rate +19.3%)
- EBITDA +570.6% YoY (vs +58.1% in previous quarter and historical rate -20.9%)
- EBITDA margin 18.0% increased compared to 5.0% same period last year
- Net Debt decreased by $1.7 bln since the start of the year (249.8% of market cap)
- FCF (LTM) -$2 bln (negative), 293.3% of market cap
- EV/Sales multiple is 1.1x
------------------------------------------------
2025-02-27
#reports #FLYW
[Flywire Corporation](https://eninvs.com/all.php?name=FLYW) (Information Technology Services) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=180947)
(2025-02-25, After Market Close):
- Revenue +16.8% YoY (vs +27.6% in previous quarter and historical rate +35.1%)
- EBITDA margin -0.8% increased compared to -5.0% same period last year
- Net Debt increased by $70 mln over the past reporting period (5.1% of market cap)
- FCF (LTM) +$1.5 bln (positive), 112.0% of market cap
- EV/EBITDA multiple is 66.4x compared to historical level (75th percentile) of 243.9x
- EV/Sales multiple is 1.6x
At the opening of the session the share price went down -48.6% vs S&P500 +0.2%
------------------------------------------------
2025-02-27
#reports #EYE
[National Vision](https://eninvs.com/all.php?name=EYE) (Optics supplier) reported for 2024 q4
(2025-02-26, Before Market Open):
- Revenue -13.6% YoY (vs -15.0% in previous quarter and historical rate -3.0%)
- EBITDA -107.1% YoY (vs +1500.0% in previous quarter)
- EBITDA margin -0.2% decreased compared to 2.8% same period last year
- Net Debt decreased by $8 mln over the past reporting period (0.8% of market cap)
- FCF (LTM) +$0 bln (positive), 2.4% of market cap
- EV/EBITDA multiple is 15.2x compared to historical level (75th percentile) of 31.6x
- EV/Sales multiple is 0.9x
At the opening of the session the share price went up +18.0% vs S&P500 +0.2%
------------------------------------------------
2025-02-27
#reports #EVTC
[EVERTEC](https://eninvs.com/all.php?name=EVTC) (Software — Infrastructure) reported for 2024 q4
(2025-02-26, After Market Close):
- Revenue +10.8% YoY (vs +22.5% in previous quarter and historical rate +13.1%)
- EBITDA +43.4% YoY (vs +22.2% in previous quarter and historical rate -0.2%)
- EBITDA margin 35.2% increased compared to 27.2% same period last year
- Net Debt decreased by $744 mln over the past reporting period (36.0% of market cap)
- FCF (LTM) +$0.1 bln (positive), 3.0% of market cap
- EV/EBITDA multiple is 9.4x compared to historical level (75th percentile) of 11.3x
- EV/Sales multiple is 3.3x
------------------------------------------------
2025-02-27
#reports #ESTA
[Establishment Labs](https://eninvs.com/all.php?name=ESTA) (Medical Devices) reported for 2024 q4
(2025-02-26, After Market Close):
- Revenue +40.6% YoY (vs +2.6% in previous quarter and historical rate +11.8%)
- EBITDA margin -91.1% increased compared to -137.5% same period last year
- Net Debt decreased by $25 mln over the past reporting period (2.5% of market cap)
- FCF (LTM) -$0 bln (negative), 0.7% of market cap
- EV/Sales multiple is 6.8x
At the opening of the session the share price went up +2.8% vs S&P500 +0.3%
------------------------------------------------
2025-02-27
#reports #ESCA
[Escalade](https://eninvs.com/all.php?name=ESCA) (Leisure) reported for 2024 q4
(2025-02-26, Before Market Open):
- Revenue -3% YoY (vs -6.8% in previous quarter and historical rate -5.8%)
- EBITDA -37.5% YoY (vs +57.1% in previous quarter and historical rate +12.1%)
- EBITDA margin 7.8% decreased compared to 12.1% same period last year
- EV/EBITDA multiple is 8.5x compared to historical level (75th percentile) of 9.8x
- EV/Sales multiple is 0.8x
At the opening of the session the share price went up +1.7% vs S&P500 +0.2%
------------------------------------------------
2025-02-27
#reports #EME
[EMCOR Group](https://eninvs.com/all.php?name=EME) (Mechanical and electrical design services) reported for 2024 q4
(2025-02-26, Before Market Open):
- Revenue +9.6% YoY (vs +15.2% in previous quarter and historical rate +13.8%)
- EBITDA +43.6% YoY (vs +54.0% in previous quarter and historical rate +32.5%)
- EBITDA margin 11.5% increased compared to 8.8% same period last year
- Net Debt decreased by $311 mln over the past reporting period (1.6% of market cap)
- FCF (LTM) +$0.2 bln (positive), 1.2% of market cap
- EV/EBITDA multiple is 13x compared to historical level (75th percentile) of 16.3x
- EV/Sales multiple is 1.3x
At the opening of the session the share price went up +5.6% vs S&P500 +0.2%
------------------------------------------------
2025-02-27
#reports #ELAN
[Elanco Animal Health](https://eninvs.com/all.php?name=ELAN) (Animal medicine manufacturer) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=181111)
(2025-02-25, Before Market Open):
- Revenue -1.4% YoY (vs -3.6% in previous quarter and historical rate -2.1%)
- EBITDA margin 0.1% increased compared to -53.0% same period last year
- Net Debt decreased by $504 mln over the past reporting period (9.6% of market cap)
- FCF (LTM) +$1.1 bln (positive), 20.2% of market cap
- EV/EBITDA multiple is 90.4x compared to historical level (75th percentile) of 31.1x
- EV/Sales multiple is 2.1x
At the opening of the session the share price went down -2.8% vs S&P500 -0.4%
------------------------------------------------
2025-02-27
#reports #EE
[Excelerate Energy, Inc.](https://eninvs.com/all.php?name=EE) (Utilities — Renewable) reported for 2024 q4
(2025-02-26, After Market Close):
- Revenue +14.6% YoY (vs -29.8% in previous quarter and historical rate -28.0%)
- EBITDA +27.7% YoY (vs -17.8% in previous quarter and historical rate +23.5%)
- EBITDA margin 30.2% increased compared to 27.1% same period last year
- Net Debt increased by $71 mln over the past reporting period (2.3% of market cap)
- FCF (LTM) +$0 bln (positive), 1.4% of market cap
- EV/EBITDA multiple is 15.3x compared to historical level (75th percentile) of 14x
- EV/Sales multiple is 5.4x
At the opening of the session the share price went up +7.4% vs S&P500 +0.3%
------------------------------------------------
2025-02-27
#reports #ECPG
[Encore Capital](https://eninvs.com/all.php?name=ECPG) (Financial services provider) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=180907)
(2025-02-26, After Market Close):
- Revenue -4% YoY (vs +18.4% in previous quarter and historical rate -4.6%)
- Net Income margin -84.6% increased compared to -97.8% same period last year
- P/S multiple is 0.9x
- Price to book: 1.1x
------------------------------------------------
2025-02-27
#reports #DRVN
[Driven Brands Holdings Inc.](https://eninvs.com/all.php?name=DRVN) (Auto and Truck Dealerships) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=180968)
(2025-02-25, Before Market Open):
- Revenue +322.4% YoY (vs +1.9% in previous quarter and historical rate +34.5%)
- EBITDA -56.5% YoY (vs +8200.0% in previous quarter and historical rate +38.0%)
- EBITDA margin 1.7% decreased compared to 16.6% same period last year
- Net Debt decreased by $54 mln over the past reporting period (2.1% of market cap)
- FCF (LTM) +$1.8 bln (positive), 69.7% of market cap
- EV/EBITDA multiple is 17.9x compared to historical level (75th percentile) of 31.2x
- EV/Sales multiple is 1.5x
At the opening of the session the share price went down -5.3% vs S&P500 -0.4%